$KBH, $MRK, $PTCT, $TMHC, $ZM
Daily HeffX-LTN reviews dozens of the Street’s Key analysts research reports to ID new trading and investing ideas for HeffX-LTN readers. Some reports cover stocks to buy, and others cover stocks to sell or avoid.
Below is a list of The Street’s Key analysts outlook for Key issues for Tuesday follows:
KB Home (NYSE:KBH) was raised to Overweight from Equal Weight and the target price was raised to 29 from 24 at Barclays. The stock has a consensus target price at 25.64.
Merck & Co. Inc. (NYSE:MRK) was raised to Overweight from Neutral at Atlantic Equities. The call was based on valuation and with its new products being likely able to outpace coming patent expiration headwinds.
PTC Therapeutics Inc. (NASDAQ:PTCT) was raised to Buy from Neutral and the price objective was raised to 49 from 43 at Merrill Lynch.
Taylor Morrison Home Corp. (NYSE:TMHC) was raised to Outperform from Neutral and the price target was raised to 24 from 22 at Wedbush. The firm’s analysts noted that the company’s proactive financing campaigns, its small exposure to California and 67% exposure to active adult and entry-level homes are all positive catalysts ahead.
Zoom Video Communications Inc. (NASDAQ:ZM) Piper Jaffray started it as Overweight with a 90 target price. Morgan Stanley started it as Equal Weight with a 75 target price. It was started with a Market Perform rating at Wells Fargo, a Sector Weight rating at KeyBanc, as Hold at Stifel and as Neutral at Goldman Sachs. JPMorgan started it with an Overweight rating.